Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
CNXU
Conexeu Sciences Inc.
NASDAQCM
Biotechnology
United States
$4.97
▼
-0.30 (-5.69%)
CLOSED
—
OPEN
$5.26
HIGH
$5.58
LOW
$4.86
PREV CLOSE
$5.27
VOLUME
249.4K
1.54x avg
MARKET CAP
$133.0M
DAY RANGE
$4.86
$5.58
P/E (TTM)
—
Fwd -9.4
EPS (TTM)
-0.34
DIV YIELD
—
52W HIGH
$18.79
-73.5%
52W LOW
$4.86
+2.4%
BETA
—
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$4.99
+0.02
(+0.40%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
CNXU
$4.97
▼
-5.69%
Chart
Valuation
Financials
Peers
News
CNXU · K 線技術分析（即時、可互動）
basic
pro
快速分析（2–5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，一般約 2 分鐘，上游壅塞時最長約 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-OFF
74 BARS · -62.0% YOY
1-year price chart. Started at 13.07, currently 4.97, down 62 percent. Range 4.97 to 16.85 over 74 data points.
2026-05-21
$13.07 → $4.97 (-62.0%)
2026-09-04
§ Valuation
Loading § Valuation
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.0%
Terminal g
+3.5%
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers. · Comparables skipped: no peer multiples or no per-share economics from Finnhub metric endpoint.
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · 2026-09-01
Conexeu Sciences Sets September and October 2026 Conference Schedule
GlobeNewswire · 2026-09-01
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
GlobeNewswire · 2026-08-18
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
GlobeNewswire · 2026-08-11
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
IPO-Edge.com · 2026-08-03
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
GlobeNewswire · 2026-07-14
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
GlobeNewswire · 2026-07-07
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
GlobeNewswire · 2026-06-25